Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $42.0 million.

  • Veracyte's Free Cash Flow rose 5138.34% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.2 million, marking a year-over-year increase of 7388.15%. This contributed to the annual value of $63.8 million for FY2024, which is 8624.38% up from last year.
  • Per Veracyte's latest filing, its Free Cash Flow stood at $42.0 million for Q3 2025, which was up 5138.34% from $32.3 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Free Cash Flow registered a high of $42.0 million during Q3 2025, and its lowest value of -$41.8 million during Q1 2021.
  • Moreover, its 5-year median value for Free Cash Flow was $7.6 million (2021), whereas its average is $7.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 89805.56% in 2022, then surged by 57452.14% in 2023.
  • Over the past 5 years, Veracyte's Free Cash Flow (Quarter) stood at $7.6 million in 2021, then increased by 3.51% to $7.9 million in 2022, then skyrocketed by 65.84% to $13.1 million in 2023, then surged by 56.13% to $20.4 million in 2024, then soared by 105.88% to $42.0 million in 2025.
  • Its Free Cash Flow stands at $42.0 million for Q3 2025, versus $32.3 million for Q2 2025 and $3.5 million for Q1 2025.